1月16日，诚益通跌5.28%，截至发稿，报24.24元/股，成交1.74亿元，换手率2.69%，总市值66.19亿 元。 资料显示，北京诚益通控制技术集团股份有限公司位于北京市大兴区生物医药产业基地庆丰西路27号， 成立日期2003年7月22日，上市日期2015年3月19日，公司主营业务涉及提供医药、生物工业自动化控制 系统整体解决方案;康复理疗医疗器械的研发、生产和销售业务。主营业务收入构成为：控制系统 54.65%，康复医疗器械28.89%，系统设备及其他16.47%。 从诚益通十大流通股东角度 数据显示，长城基金旗下1只基金位居诚益通十大流通股东。长城消费增值混合A（200006）三季度新 进十大流通股东，持有股数200万股，占流通股的比例为0.77%。根据测算，今日浮亏损失约270万元。 长城消费增值混合A（200006）成立日期2006年4月6日，最新规模5.16亿。今年以来收益21.73%，同类 排名56/8847；近一年收益44.1%，同类排名2734/8094；成立以来收益315.35%。 长城消费增值混合A（200006）基金经理为龙宇飞。 截至发稿，龙宇飞累计任职时间8年93天，现任基金 ...

Core Viewpoint - Hongbo Pharmaceutical's stock increased by 5.06% to 30.94 CNY per share, with a total market capitalization of 4.319 billion CNY as of November 24 [1] Company Overview - Hongbo Pharmaceutical, established on December 14, 2007, is located in the Pudong New Area of Shanghai and was listed on November 1, 2022 [1] - The company's main business includes drug discovery, pharmaceutical process research and development, and commercial production of raw material intermediates [1] - Revenue composition: Drug discovery accounts for 52.67%, commercial production 35.00%, process research and development 8.10%, and other activities 4.23% [1] Shareholder Information - Changcheng Fund's Changcheng Consumption Value Mixed A (200006) is among the top ten circulating shareholders of Hongbo Pharmaceutical, holding 1.6009 million shares, unchanged from the previous period, representing 2.08% of circulating shares [2] - The fund has an estimated floating profit of approximately 2.3854 million CNY as of today [2] Fund Performance - Changcheng Consumption Value Mixed A (200006) was established on April 6, 2006, with a current scale of 516 million CNY [2] - Year-to-date return is 14.39%, ranking 4459 out of 8209 in its category; one-year return is 6.92%, ranking 5776 out of 8129; and since inception, the return is 232.84% [2] Fund Manager Information - The fund manager of Changcheng Consumption Value Mixed A is Long Yufei, who has been in the position for 8 years and 40 days [3] - The total asset size of the fund is 843 million CNY, with the best return during the tenure being 61.42% and the worst return being -8.9% [3] Fund Holdings - Changcheng Consumption Value Mixed A (200006) has Hongbo Pharmaceutical as its sixth-largest holding, with 1.6009 million shares, accounting for 6.61% of the fund's net value [4] - The estimated floating profit for the fund from this holding is approximately 2.3854 million CNY [4]